Yep. Imugene are so smart they engineered themselves a cash tap that they will just keep running for the next 2.5 years. Isn’t it phenomenal the amount of trials we have concluding, underway, and commencing now; yet there is no need whatsoever to worry about funding for literally years. We have more than $70million in cash, options and research rebates on the way.
Ann: Change of Director's Interest Notice - LR, page-7
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
